M Kathleen Dyke, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1901 1st Ave, Rock Falls, IL 61071 Phone: 815-626-6803 Fax: 815-626-6818 |
Beth Jacobs, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 1st Ave, Rock Falls, IL 61071 Phone: 815-626-9562 |
Dr. Daniel Charles Doddroe, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 1st Ave, Rock Falls, IL 61071 Phone: 815-626-9562 |
Amber Leigh Nugent, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1901 1st Ave, Rock Falls, IL 61071 Phone: 815-626-6803 |
Brooke Horner Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 1st Ave, Rock Falls, IL 61071 Phone: 815-626-9562 Fax: 815-626-0256 |
Mrs. Amy Christine Mandrell, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 1st Ave, Rock Falls, IL 61071 Phone: 815-626-9562 |
Dr. Tyler Lee Davis, PHARMD, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 1st Ave, Rock Falls, IL 61071 Phone: 815-626-9562 |
Jennifer Lynn Foust, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1901 1st Ave, Rock Falls, IL 61071 Phone: 815-626-6803 Fax: 815-626-6818 |
News Archive
Determining whether a patient's lung cancer has spread to nearby lymph nodes is critical for identifying the most effective therapy, but it usually requires surgery. A new study suggests, however, that measuring levels of a particular molecule in a sample of tumor tissue might accurately answer the question.
The Developmental Origins of Health and Disease (DOHaD) hypothesis is supported by multiple human epidemiological studies and animal studies.
When cells are confronted with an invading virus or bacteria or exposed to an irritating chemical, they protect themselves by going off their DNA recipe and inserting the wrong amino acid into new proteins to defend them against damage, scientists have discovered.
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has entered into an exclusive agreement with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), to market the authorized generic version of Concerta® (methylphenidate hydrochloride extended-release tablets). Watson will launch its authorized generic of Concerta on May 1, 2011. Concerta is indicated for the treatment of attention deficit hyperactivity disorder (ADHD).
Chindex International, a leading independent American provider of Western healthcare products and services in the People's Republic of China, and Shanghai Fosun Pharmaceutical, a leading manufacturer and distributor of western and Chinese medicine and devices in China, today announced the formation of the previously-proposed joint venture to independently operate certain combined medical device businesses, including Chindex's Medical Products division.
› Verified 3 days ago